S1 Ep22: Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment episode artwork

EPISODE · Jul 26, 2021 · 10 MIN

S1 Ep22: Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

from EyePod · host Ophthalmology Times

Elizabeth Yeu, MD, a cornea cataract and refractive surgeon at Virginia Eye Consultants shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of a new investigational therapeutic from Tarsus Pharmaceuticals called TP03 (lotilaner ophthalmic solution 0.25%), for the treatment of patients diagnosed with Demodex blepharitis.

Episode metadata supplied by the publisher feed · Published Jul 26, 2021

Embed this episode

NOW PLAYING

S1 Ep22: Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

0:00 10:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of EyePod?

This episode is 10 minutes long.

When was this EyePod episode published?

This episode was published on July 26, 2021.

Can I download this EyePod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!